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Abstract
Background: Keloids are benign skin tumors that are the effect of a dysregulated wound-healing
process in genetically predisposed patients. They are inherited with an autosomal dominant mode
with incomplete clinical penetrance and variable expression. Keloids are characterized by
formation of excess scar tissue beyond the boundaries of the wound. The exact etiology is still
unknown and there is currently no appropriate treatment for keloid disease.
Methods: We analyzed sample tissues obtained from 20 patients with keloid skin lesions and
normal skin obtained from 20 healthy donors as control. The telomeres were measured by
Terminal Restriction Fragment (TRF) analysis and Real-Time PCR assay. Quantitative Real-Time
RT-PCR analysis of hTERT gene expression was performed and intracellular ROS generation was
measured.
Results: In this study, we determined whether telomeric shortening and the expression of human
telomerase reverse transcriptase (hTERT) occurs in keloid patients. Using Terminal Restriction
Fragment (TRF) analysis and Real-Time PCR assay, we detected a significant telomere shortening
of 30% in keloid specimens compared to normal skin. Using quantitative Real-Time RT-PCR,
telomerase activity was found absent in the keloid tissues. Moreover, an increase in ROS
generation was detected in fibroblasts cell cultures from keloid specimens as more time elapsed
compared to fibroblasts from normal skin.
Conclusion: Telomere shortening has been reported in several metabolic and cardiovascular
diseases. We found that telomere shortening can also be associated with human keloids. Chronic
oxidative stress plays a major role in the pathophysiology of several chronic inflammatory diseases.
Here we found increased ROS generation in fibroblasts from keloid fibroblasts cell cultures when
compared to normal skin fibroblasts. Hence we conclude that oxidative stress might be an
important modulator of telomere loss in keloid because of the absence of active telomerase that
counteracts telomere shortening.
Background
Keloids (OMIM 148100) are benign skin tumors occur-
ring during wound healing in genetically predisposed
patients. The pattern of inheritance observed in 14 pedi-
grees with familial keloids has been consistent with an
autosomal dominant mode with incomplete clinical pen-
etrance and variable expression [1]. Keloids are character-
ized by the proliferation of dermal fibroblasts,
overproduction of extracellular matrix components
(ECM), an increased infiltration of inflammatory cells
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including lymphocytes, mast cells (MCs) and macro-
phages. Keloids spread to invade normal skin beyond the
boundaries of the original wound and do not regress
spontaneously [2]. Previously, we showed that keloids
differed from what we found in hypertrophic scars in that
p53 down regulation, together with the increased ΔNp63
expression, could contribute to keloid development by
means of accumulation of continuously proliferating cells
[3]; we also found a significant increase in ROS (reactive
oxygen species) generation in keloid fibroblasts, a phe-
nomenon that probably relates to the inflammatory and
oxidative stress status of the disease [3]. It is reasonable to
believe that the lack of effective therapies is due to an
insufficient understanding of the disease pathology. This
is partially because the study of keloid biology is hindered
by the lack of a well-established animal model for the dis-
ease. Telomeres, the TTAGGG tandem repeats at chromo-
somal ends, become progressively shorter with each
replication of somatic cells. Telomerase is a reverse tran-
scriptase that synthesizes the telomeric sequence, which
prevents telomere shortening and thereby prolongs the
lifespan of cells. Activation of telomerase is determined by
the expression of the telomerase reverse transcriptase
(hTERT) mRNA. This enzyme, which is known to play a
major role in telomeres maintenance, is present in the
majority of cancer and germ cells as well as in normal
endothelium, while enzyme activity is absent in most nor-
mal human somatic cells [4]. It has reported that oxidative
stress is an important modulator of telomere loss and that
telomere-driven replicative senescence is primarily a stress
response [5]. Telomere shortening has been found in sev-
eral inflammatory diseases such as vascular diseases, Type
2 Diabetes, Fanconi anaemia, Ataxia Telangiectasia [6-9].
There are no available data on telomere length in human
keloids, and we hypothesized that keloid patients would
demonstrate shorter telomeres compared with control
subjects and that this would be directly related to markers
of oxidative DNA damage.
Thus, the purpose of this study was to compare the tel-
omere length of keloids patients and control subjects;
moreover, we investigated the possible role of telomerase
in keloids determining the expression of human telomer-
ase reverse transcriptase (hTERT) mRNA, which is the
minimal component needed for telomerase activity. This
is the first report, to our knowledge, showing telomere
shortening in human keloids.
Results
For measuring telomere length, Terminal Restriction Frag-
ment (TRF) analysis and Real-Time PCR assay were both
used in all samples. Among the 20 keloid patients, the
mean (+/- SD) telomere length was significantly lower in
the patients with keloids (4.12 ± 0.2 kb) compared with
the 20 control subjects (6.070 ± 0.6 kb) (*P < 0. 05) (Fig-
Quantitative estimation of the telomeres shortening rate (%) between normal skin and keloid Figure 1
Quantitative estimation of the telomeres shortening rate (%) between normal skin and keloid. Telomere short-
ening rate in normal skin and keloid specimens. Data are mean (± SE) of telomere lengths from the 20 controls and the 20 
patients with keloids measured in triplicate. The asterisk indicates a significant difference between normal skin and keloids with 
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ure 1 and 2). Therefore, it was reasonable to hypothesize
that telomerase, the reverse transcriptase that elongates
telomeres through the de novo synthesis of TTAGGG
repeats, was more inactive in keloid patients. To investi-
gate the possible role of telomerase activity in human kel-
oid, we analyzed hTERT expression level, by a quantitative
RT-PCR assay using primer pairs specific for hTERT mRNA
in either keloid skin and normal skin. hTERT expression
was assayed in the tip and in the edge of the keloid speci-
mens and in the adjacent normal skin, but the level was
undetectable. hTERT expression was assayed in the tip and
in the edge of the normal skin specimens too and no sig-
nificant expression was detected (data not shown). Here,
we made fibroblasts cell cultures from the 20 keloid and
normal skin specimens used in this study. An increase in
ROS generation was detected in fibroblasts cell cultures
from keloid specimens with elapsing time, peaking at 72
hours, compared to fibroblasts from normal skin (Figure
3). Decreased telomere lengths were significantly corre-
lated with ROS levels (r = -0.94) in fibroblasts from keloid
specimens (Figure 4).
Discussion
Shortening of telomeres has been reported to be present
in patients with inherited respiratory chain disorders [10],
Down's syndrome [11], vascular dementia [12] and
ataxia-telangiectasia [13]. Recent studies have also shown
that telomere shortening can be a biomarker of premature
cell senescence in vascular diseases and metabolic disor-
ders [14-16]. Our study is the first to demonstrate a short-
ened TRF length in patients with keloids. It is still
controversial if there is a correlation between telomerase
activity and hTERT expression. In humans, telomerase
activity is detected in germ cells and in nearly all malig-
nant tumor cells. Telomerase is not detected in the major-
ity of somatic cells except for in a few somatic cells such as
lymphocytes and endometrium of the uterus [17]. hTERT,
the core component of human telomerase, is detected
only in cells and tissues positive for telomerase activity,
but it is not present in normal somatic cells lacking telom-
erase activity. It was recently reported that several normal
tissues lack telomerase activity despite expressing hTERT
mRNA [18,19]. Furthermore, the cellular defending func-
tion of telomerase has been correlated to an increased
apoptosis resistance and to DNA damage repair. It has
been shown that oxidative stress induces the depletion of
human telomerase reverse transcriptase hTERT from the
nucleus through the nuclear pores into the cytosol
[20,21].
Telomere length and attrition rate may be prognostic for
several forms of cardiovascular diseases, particularly if
oxidative stress outlines in the development of these dis-
eases [22]. Telomeric DNA is more sensitive to oxidative
damage than the whole genome; indeed telomeres are
particularly prone to damage at the GGG sequence com-
pared with the rest of chromosomal DNA and relatively
modest degrees of oxidative DNA damage could be
expressed as substantial telomere attrition. Interestingly,
patients with ROS production due to mitochondrial DNA
defects also had shortened telomeres and oxidative stress
caused enhanced telomere shortening and loss of func-
tion in Fanconi Anaemia cells [23];moreover, cells from
patients with ataxia-telangiectasia show enhanced sensi-
tivity of telomeric DNA to oxidative stress [24] Recent
studies have demonstrated that chronic oxidative stress
interferes with telomere maintenance at two levels: it
increases the basal rate of telomere shortening by induc-
tion of telomeric DNA damage, as shown before in telom-
erase-negative fibroblasts, and it prevents telomerase from
counteracting telomere shortening by inducing its export
from the nucleus and to mitochondria; telomerase can be
excluded from the nucleus in parallel with ROS genera-
tion [25]. In a previous study we found a significant
increase in ROS (reactive oxygen species) generation in
fibroblast cell cultures from keloid patients compared to
fibroblasts cell cultures from normal patients, a phenom-
Telomere Southern blot of normal skin and keloid specimens Figure 2
Telomere Southern blot of normal skin and keloid 
specimens. Terminal restriction fragment length (TRF) was 
determined by Southern blot analysis and a subsequent den-
sitometric analysis. Equivalent amounts of genomic DNA 
were loaded in each lane. (1-5) TRF length of normal skin and 
(6-10) keloid specimens.BMC Medical Genetics 2009, 10:110 http://www.biomedcentral.com/1471-2350/10/110
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enon that probably relates to the inflammatory and oxida-
tive stress status of the disease [3]. These results have been
confirmed here, since a significant increase in ROS gener-
ation was detected in keloid fibroblasts cell cultures from
keloid specimens when compared to normal fibroblasts.
It is possible to hypothesize that oxidative stress may
modify TRF length in keloids; otherwise a diminished TRF
length could take place for telomere attrition due to an
increased turnover and chronic activation of inflamma-
tory cells. Telomere attrition can be an independent kel-
oid risk factor or a consequence of the disease, since
accelerated shortening of telomere length could simply be
a surrogate for the chronic oxidative stress and/or inflam-
mation.
We propose that, such as in other inflammatory diseases,
oxidative stress might contribute to telomere shortening
in human keloids.
Conclusion
Our study, for the first time, reported that there is an asso-
ciation between telomere length and keloids, with age and
gender adjusted; however, a larger-scale study is required
to explore the potential role of environmental (oxidative
and more) stresses in the mechanism of telomere shorten-
ing in human keloids.
Methods
Keloid samples and DNA extraction
Since telomere length is inversely related to chronological
age and was greater in women than in men, the effects of
age and sex were controlled to obtain an absolute rela-
tionship between keloids and telomere length. All sub-
jects (20 patients with keloids and 20 without) were
males, within an age range of 25-35 years, and the age of
the scar was between 10-12 months old (Table 1). Fresh
tissues were obtained from patients with keloid skin
lesions and normal skin was obtained from healthy
donors.
The study was performed with the patients informed con-
sent and approved by the Ethic Committee of the Univer-
sity of Naples (Italy) in compliance with the Helsinki
Declaration.
Genomic DNA was prepared from skin specimens using
DNA Isolation Kit for Cells and Tissues (Roche, Man-
nheim, Germany).
TRF length analysis
The telomeres were measured using a TeloTAGGG Tel-
omere Length Assay (Roche, Mannheim, Germany) fol-
lowing the manufacturer's recommendations, and also
measured using a Real-Time PCR method, as described by
Cawthon [26].
ROS generation Figure 3
ROS generation. Intracellular ROS generation was determined by measuring the fluorescence intensity of the oxidation-sen-
sitive fluorescein DCFH-DA of fibroblasts cell culture from the 20 normal and keloid specimens respectively in time course 
experiments at 48, 72 and 96 hours. The histogram shows the mean values ± SD of ROS generation obtained by analysis of 
three separate experiments. * P < 0.05BMC Medical Genetics 2009, 10:110 http://www.biomedcentral.com/1471-2350/10/110
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Real-Time Quantitative RT-PCR for hTERT
Total RNA from skin specimen and quantitative Real-
Time RT-PCR analysis of hTERT gene expression was per-
formed as already reported [27].
Cell cultures
Fibroblasts from keloids and normal skin were isolated
from samples following the method established by Lim et
al [28].
Measurement of ROS generation
The intracellular ROS generation was measured by incu-
bating the cells in the presence of 2',7'-dichlorodihy-
drofluorescein diacetate (DCFH-DA) (Calbiochem).
DCFH-DA is a stable, non-fluorescence molecule able to
cross the cell membranes and is hydrolyzed by intracellu-
lar esterases to the non-fluorescent probe DCFH, that in
turn is rapidly oxidized in the presence of peroxides to the
highly fluorescent 2',7'-dichlorofluorescein (DCF). Cells
(3.5 × 105/mL) were loaded with 1 μM DCFH-DA for 30
min at 37°C in standard medium, whose composition in
mM was: NaCl 138, KCl 2.7, CaCl2 1.2, MgCl2 1.2, phos-
phate-buffered saline (PBS) 10, glucose,10, pH 7.4. After
the loading period, cells were washed twice with phos-
phate buffered medium before the experiment was per-
formed. Acquisition data were obtained using a
fluorescent sensitive camera Cool Snap (Media Cybernet-
ics Inc., Silver Spring, MD, USA) and cells were evidenced
by a complex software Image-Pro Plus 4.5 (Media Cyber-
netics Inc.) by which areas were examined.
Statistical analysis
All results shown are mean +/- SD of at least three separate
experiments, measuring each parameter by triplicate (n =
3). Statistical significant differences were tested by one
way analysis of variance (ANOVA), and, when the F value
was significant, by Student-Newman-Keul' s test. P value
less than 0.05 (*) was considered statistically significant.
In addition, we computed Pearson correlation coefficient
to describe associations between measures.
Table 1: Clinical characteristics of the study subjects
Parameters Control
(n = 20)
Patients with keloids (n = 20)
Age (years) 25-35 25-35
Gender male Male
Age of the scar (months) 10-12
Mean (± SD) Telomere kb Length. * P < 0.05 6.070 ± 0.6 kb 4.12 ± 0.2
ROS and telomere length correlation Figure 4
ROS and telomere length correlation. Relationship between ROS generation and telomere length in keloids. Data shown 
were obtained from 20 keloid patients (r = -0.94) P < 0.01.Publish with BioMed Central    and   every 
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